Sitosterolemia: Clinical Trials

6 trials for Sitosterolemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 3 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Unknown 1
Phase 32Completed 2

Follow Sitosterolemia: new trials by email Literature Review of Sitosterolemia trials Research Report on Sitosterolemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Fish Oil and Colesevelam (STAIR7007)
Colesevelam, Fish Oil, Combination of fish oil and colesevelam - Sitosterolemia
Not applicableUnknownUniversity of Manitoba132018-02-062020-11-10
Sitosterolemia Metabolism
Ezetimibe - Sitosterolemia
Not applicableCompletedUniversity of Manitoba82012-04-012020-01-30
The Effect of Dietary Sitosterol on Blood Sugar and Cholesterol
High/Low Sitosterol - Sitosterolemia
Not applicableCompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)142007-09-102018-05-21
Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia
SCH-58235, Ezetimibe - Heart Diseases, Metabolism, Inborn Errors
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)32004-12-012008-03-04
An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)
MK0653, ezetimibe, Comparator: placebo - Lipid Metabolism, Inborn Errors, Heart Disease
Phase 3CompletedOrganon and Co302004-10-012024-08-15
Genetic Study of Sitosterolemia
genetic testing - Lipid Metabolism, Inborn Errors, Sitosterolemia
CompletedNational Center for Research Resources (NCRR)1999-11-012005-06-24

Narrower conditions

Heart Diseases (2)  ·  Lipid Metabolism, Inborn Errors (2)  ·  Metabolism, Inborn Errors (2)  ·  Atherosclerosis (1)  ·  Endocrine System Diseases (1)  ·  Insulin Resistance (1)  ·  Rare Diseases (1)

Broader conditions

Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Cardiovascular Diseases (2)  ·  Lipid Metabolism Disorders (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Disease Attributes (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Metabolism, Inborn Errors (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Ezetimibe (3)  ·  Colesevelam Hydrochloride (1)  ·  Docosahexaenoic Acids (1)  ·  Fish Oils (1)  ·  Genetic Testing (1)

Sponsors

University of Manitoba (2)  ·  National Center for Research Resources (NCRR) (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Organon and Co (1)

Countries

United States (3)  ·  Canada (2)

Top investigators

Kong Y Chen, Ph.D. (1)  ·  Peter J Jones, PhD (1)  ·  Semone B Myrie, PhD (1)  ·  Shailesh B. Patel (1)

Results publications

PMID 25444527, PMID 28625503